Duke University
Duke University received $58.1M in federal prime contract obligations in the 12 months ending Oct 5, 2026, up 50.5% from $38.6M the year before, and $340.5M since FY2022. Its largest customer is the Department of Health and Human Services.
See 6 contracts ending in the next 18 months ↓Contractor details
- Unique Entity ID (UEI)
- TP7EK8DZV6N5
- CAGE code
- 4B478
- Headquarters
- Durham, NC
- Business size
- Other Than Small Business
As recorded on this UEI's most recent prime contract action in USAspending.gov. Confirm current registration and certifications in SAM.gov.
Obligations by fiscal year
Net prime contract obligations by federal fiscal year.
Markets where it ranks top 10
Agency and NAICS markets where this UEI is one of the ten largest primes in the latest 12 months.
HHS · NAICS 621991
#3HHS · NAICS 622110
#4HHS · NAICS 541715
#5VA · NAICS 541714
#5Top agencies
Funding agencies ranked by obligations since FY2022.
| Funding agency | Latest 12 mo | Since FY2022 |
|---|---|---|
| Department of Health and Human Services | $55.4M | $320.2M |
| Department of Defense | $1.4M | $12.5M |
| Department of Veterans Affairs | $780K | $4.9M |
| Department of Homeland Security | $0 | $1.2M |
| National Aeronautics and Space Administration | $461K | $991K |
| Environmental Protection Agency | $0 | $327K |
Top NAICS codes
Industry codes agencies recorded on this contractor's awards, since FY2022.
| NAICS | Industry | Latest 12 mo | Since FY2022 |
|---|---|---|---|
| 541715 | Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | $43.8M | $218.7M |
| 541714 | Research and Development in Biotechnology (except Nanobiotechnology) | $7.2M | $64.8M |
| 621991 | Blood and Organ Banks | $4.5M | $25.4M |
| 622110 | General Medical and Surgical Hospitals | $2.1M | $6.3M |
| 541690 | Other Scientific and Technical Consulting Services | −$19K | $5.2M |
| 611310 | Colleges, Universities, and Professional Schools | $857K | $4.1M |
What it sells
Product and service codes (PSC) on this contractor's awards, since FY2022.
| PSC | Description | Since FY2022 |
|---|---|---|
| AN12 | Health R&D services; Health Care services; Applied Research | $216.1M |
| AN11 | Health R&D services; Health Care services; Basic Research | $45.0M |
| Q508 | Hematology & Oncology | $25.4M |
| AN81 | R&D- medical: Aids Research (Basic Research) | $13.3M |
| B537 | Special Studies/Analysis- Medical/Health | $6.3M |
| AJ11 | General Science and Technology R&D services; General Science and technology; Basic Research | $5.7M |
Contracts ending in the next 18 months
This contractor's largest awards whose current period of performance ends soon. Options and extensions often move these dates.
| Award | Agency | Obligated | Current end |
|---|---|---|---|
| 75N93023F00001 | Department of Health and Human Services THE PURPOSE OF THIS TASK ORDER IS TO (A) ACQUIRING, PROCURING AND/OR MANUFACTURING MATERIALS REQUIRED FOR THE GENERATION OF A SCALABLE IN VITRO TRANSCRIPTION (IVT) REACTION, THE… | $6.8M | Mar 28, 2027 |
| 75N94022F00002 | Department of Health and Human Services THE PURPOSE OF THIS TASK ORDER IS TO IDENTIFY THE REMAINING GAPS IN OFF-LABEL USE IN CHILDREN AND TO DESIGN CLINICAL RESEARCH (SYSTEMATIC LITERATURE REVIEWS, EPIDEMIOLOGY… | $5.8M | Jul 12, 2027 |
| 75N93019C00050 | Department of Health and Human Services THIS CONTRACT WILL SUPPORT COMPONENT A OF THE COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) PROGRAM TO DESIGN AND EVALUATE INNOVATIVE INFLUENZA VACCINE APPROACHES,… | $41.4M | Jul 28, 2027 |
| 75N94023F00004 | Department of Health and Human Services BPCA INNOVATIVE TRIAL DESIGNS AND ASSAY DEVELOPMENTS IN PEDIATRIC THERAPEUTICS | $8.8M | Sep 27, 2027 |
| 75N93024F00001 | Department of Health and Human Services EXTERNAL QUALITY ASSURANCE PROGRAM OVERSIGHT LABORATORY (EQAPOL) | $12.1M | Sep 29, 2027 |
| 75N93021C00010 | Department of Health and Human Services IMMUNOLOGY QUALITY ASSESSMENT (IQA) PROGRAM | $9.2M | Sep 29, 2027 |
Recent awards
This contractor's newest prime contract awards, most recent first.
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| 7571MN26C00048 | Department of Health and Human Services NATIONAL DATA ARCHIVE ON CHILD ABUSE AND NEGLECT (NDACAN) OPERATIONS AND MAINTENANCE (O&M) SERVICES FOR ACF/CB THIS IS A DOI CONTRACT #140D0422P0227, THAT IS TRANSFERRED TO… | $1.4M | Sep 29, 2026 |
| 75F40126C00081 | Department of Health and Human Services EO14398 - BROAD AGENCY ANNOUNCEMENT (BAA) FY26C1IP1 VALID APPROACHES TO INTEGRATING PATIENT SCIENCE INTO MEDICAL DEVICE STUDIES | $750K | Sep 26, 2026 |
| 75D30126F00004 | Department of Health and Human Services CISA HOME LAIV STUDY- LEAD SITE, EO 14398 | $1.9M | Sep 25, 2026 |
| 75N94026F00002 | Department of Health and Human Services NICHD: R&D: BESPOKE GENE THERAPY CONSORTIUM (BGTC) - SUPPORT FOR NIH-SPONSORED CLINICAL TRIALS: NON-SEVERABLE | $8.3M | Sep 24, 2026 |
| 75F40126C00112 | Department of Health and Human Services EO14398 - BROAD AGENCY ANNOUNCEMENT (BAA) FY26C1IP3 - ADVANCED RESEARCH AND DEVELOPMENT OF REGULATORY SCIENCE - CORE CLINICAL OUTCOME ASSESSMENT GRANT PROGRAM | $1.5M | Sep 24, 2026 |
| 123A9426P0037 | Department of Agriculture UNTARGETED METABOLOMIC ANALYSIS OF PLANT EXTRACTS (SUGARCANE) FOR THE COMMODITY UTILIZATION RESEARCH UNIT AT SRRC. | $30K | Sep 22, 2026 |
| 75N94026F00001 | Department of Health and Human Services NICHD: R&D: INNOVATIVE TRIAL DESIGNS AND LABS 2.0: NON-SEVERABLE | $5.7M | Sep 21, 2026 |
| 75F40126C00181 | Department of Health and Human Services FIRM FIXED PRICE AWARD TOWARDS ML-POWERED, EFFICIENT AND ROBUST INFERENCE OF AVERAGE AND INDIVIDUAL TREATMENT EFFECTS FOR NOVEL CLINICAL TRIALS IN RARE DISEASES CONTRACTING… | $1.3M | Sep 18, 2026 |
Entities under Duke University
UEIs that report the same ultimate parent in SAM.gov. Ownership records can lag acquisitions.
Prime contracts (award types A–D) from USAspending.gov through Oct 5, 2026. Subcontracts are not included. Net obligations include deobligations and corrections.
Ready to connect your pursuit work?
GovEagle gives BD directors, capture managers, and proposal teams one AI workspace from pipeline through proposal, with CMMC/FedRAMP Certified compliance built in.